Elobixibat for the treatment of constipation

References

• Shin A, Camilleri M, Vijayvargiya P, et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11(10):1270–1275 e1271.
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, Carlson P, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012;10(9):1009–1015 e1003.
   PubMed Web of Science ®Google Scholar
• Wedlake L, A’Hern R, Russell D, et al. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by sehcat scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Therapeut. 2009;30(7):707–717.
   PubMed Web of Science ®Google Scholar
• Valentin N, Camilleri M, Altayar O, et al. Biomarkers for bile acid diarrhea in functional bowel disorder with diarrhea: a systematic review and meta-analysis. Gut. 2016;65(12):1951–1959.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M. Update on bile acid malabsorption: finally ready for prime time? Curr Gastroenterol Rep. 2018;20(3):10.
   PubMedGoogle Scholar
• Conley DR, Coyne MJ, Bonorris GG, et al. Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit. Am J Dig Dis. 1976;21(6):453–458.
   PubMedGoogle Scholar
• Ao M, Sarathy J, Domingue J, et al. Chenodeoxycholic acid stimulates cl(-) secretion via camp signaling and increases cystic fibrosis transmembrane conductance regulator phosphorylation in t84 cells. Am J Physiol Cell Physiol. 2013;305(4):C447–C456.
   PubMed Web of Science ®Google Scholar
• Domingue JC, Ao M, Sarathy J, et al. Chenodeoxycholic acid requires activation of egfr, epac, and ca2+ to stimulate cftr-dependent cl- secretion in human colonic t84 cells. Am J Physiol Cell Physiol. 2016;311(5):C777–C792.
   PubMed Web of Science ®Google Scholar
• Kawamata Y, Fujii R, Hosoya M, et al. A g protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278(11):9435–9440.
   PubMed Web of Science ®Google Scholar
• Borg JF, Wu Q, Lajczak N, et al. Regulated expression of the na+/k+-atpase pump in colonic epithelium by bile acids. FASEB J. 2017;31(Suppl. 1):856.
   Google Scholar
• Suhail M. Na+, k+-atpase: ubiquitous multifunctional transmembrane protein and its relevance to various pathophysiological conditions. J Clin Med Res. 2010;2(1):1–17.
   PubMedGoogle Scholar
• Cipriani S, Mencarelli A, Chini MG, et al. The bile acid receptor gpbar-1 (tgr5) modulates integrity of intestinal barrier and immune response to experimental colitis. PloS one. 2011;6(10):e25637.
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Gaginella TS, Carlson GL, et al. Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon. J Labor Clin Med. 1979;94(5):661–674.
   PubMed Web of Science ®Google Scholar
• Jayashree S, Jo DS, Mei A, et al. The yin and yang of bile acid action on tight junctions in a model colonic epithelium. Physiol Rep. 2017;5(10):e13294.
   PubMed Web of Science ®Google Scholar
• Keely SJ, Scharl MM, Bertelsen LS, et al. Bile acid-induced secretion in polarized monolayers of t84 colonic epithelial cells: structure-activity relationships. Am J Physiol-Gastrointestinal Liver Physiol. 2007;292(1):G290–G297.
   PubMed Web of Science ®Google Scholar
• Yde J, Borg J, Fenton RA, et al. Altered expression of aquaporin water channels in a rat model of chronic diarrhea due to bile acid malabsorption. FASEB J. 2017;31(1_supplement). 703.714.
   Google Scholar
• Ma T, Verkman AS. Aquaporin water channels in gastrointestinal physiology. J Physiol. 1999;517(Pt 2):317–326.
   PubMed Web of Science ®Google Scholar
• Bardhan PK, Rahman ASM, Islam S, et al. Effects of tropisetron, a 5-hydroxytryptamine type 3 receptor blocker, on intestinal secretion induced by cholera toxin or deoxycholic acid in rabbits in vivo. J Int Med Res. 1993;21(6):323–333.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Murphy R, Chadwick VS. Pharmacological inhibition of chenodeoxycholate-induced fluid and mucus secretion and mucosal injury in the rabbit colon. Dig Dis Sci. 1982;27(10):865–869.
   PubMed Web of Science ®Google Scholar
• Zimmerman TW, Binder HJ. Serotonin-induced alteration of colonic electrolyte transport in the rat. Gastroenterology. 1984;86(2):310–317.
   PubMed Web of Science ®Google Scholar
• Duboc H, Tolstanova G, Yuan PQ, et al. Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor tgr5 agonist, int-777: role of submucosal neurons. Neurogastroenterol Motil. 2016;28(11):1663–1676.
   PubMed Web of Science ®Google Scholar
• Ward JB, Mroz MS, Keely SJ. The bile acid receptor, tgr5, regulates basal and cholinergic-induced secretory responses in rat colon. Neurogastroenterol Motil. 2013;25(8):708–711.
   PubMed Web of Science ®Google Scholar
• Bunnett NW. Neuro-humoral signalling by bile acids and the tgr5 receptor in the gastrointestinal tract. J Physiol. 2014;592(14):2943–2950.
   PubMed Web of Science ®Google Scholar
• Alemi F, Poole DP, Chiu J, et al. The receptor tgr5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice. Gastroenterology. 2013;144(1):145–154.
   PubMed Web of Science ®Google Scholar
• Poole DP, Godfrey C, Cattaruzza F, et al. Expression and function of the bile acid receptor gpbar1 (tgr5) in the murine enteric nervous system. Neurogastroenterol Motil. 2010;22(7):814–825, e227–818.
   PubMed Web of Science ®Google Scholar
• Mekhjian HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig Dis Sci. 1979;24(7):545–550.
   PubMed Web of Science ®Google Scholar
• Kirwan WO, Smith AN, Mitchell WD, et al. Bile acids and colonic motility in the rabbit and the human. Gut. 1975;16(11):894–902.
   PubMed Web of Science ®Google Scholar
• Taylor I, Basu P, Hammond P, et al. Effect of bile acid perfusion on colonic motor function in patients with the irritable colon syndrome. Gut. 1980;21(10):843–847.
   PubMed Web of Science ®Google Scholar
• Flynn M, Hammond P, Darby C, et al. Effects of bile acids on human colonic motor function in vitro. Digestion. 1982;23(3):211–216.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Nadeau A, Tremaine WJ, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphac4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009;21(7):734–e743.
   PubMed Web of Science ®Google Scholar
• Johnston IM, Nolan JD, Pattni SS, et al. Characterizing factors associated with differences in fgf19 blood levels and synthesis in patients with primary bile acid diarrhea. Am J Gastroenterol. 2016;111(3):423–432.
   PubMed Web of Science ®Google Scholar
• Walters JR, Tasleem AM, Omer OS, et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol. 2009;7(11):1189–1194.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Busciglio I, Burton D, et al. Bile acid deficiency in a subgroup of patients with irritable bowel syndrome with constipation based on biomarkers in serum and fecal samples. Clin Gastroenterol Hepatol. 2018;16(4):522–527.
   PubMed Web of Science ®Google Scholar
• Chiang JYL. Bile acid metabolism and signaling. Comp Physiol. 2013;3(3):1191–1212.
   PubMed Web of Science ®Google Scholar
• Vijayvargiya P, Camilleri M, Shin A, et al. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol. 2013;11(10):1232–1239.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lip Res. 2006;47(2):241–259.
   PubMed Web of Science ®Google Scholar
• Koop I. Role of bile acids in the control of pancreatic secretion and cck release. Eur J Clin Inves. 1990;20(Suppl 1):S51–S57.
   PubMedGoogle Scholar
• Camilleri M. Advances in understanding of bile acid diarrhea. Expet Rev Gastroenterol Hepatol. 2014;8(1):49–61.
   PubMed Web of Science ®Google Scholar
• Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014;592(14):2967–2980.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66(4):948–983.
   PubMed Web of Science ®Google Scholar
• Ge Z, Duan Z, Yang H, et al. Home-based transcutaneous neuromodulation improved constipation via modulating gastrointestinal hormones and bile acids. Evid Based Complement Alternat Med. 2018;2018:2086163. Apr 29.
   PubMedGoogle Scholar
• Slattery SA, Niaz O, Aziz Q, et al. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Therapeut. 2015;42(1):3–11.
   PubMed Web of Science ®Google Scholar
• Bampton PA, Dinning PG, Kennedy ML, et al. The proximal colonic motor response to rectal mechanical and chemical stimulation. Am J Physiol Gastrointest Liver Physiol. 2002;282(3):G443–G449.
   PubMed Web of Science ®Google Scholar
• Mekjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest. 1971;50(8):1569–1577.
   PubMed Web of Science ®Google Scholar
• Traub RJ, Tang B, Ji Y, et al. A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology. 2008;135(6):2075–2083.
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Rodriguez-Stanley S, Zubaidi S, et al. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig Dis Sci. 2005;50(1):81–85.
   PubMed Web of Science ®Google Scholar
• Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, et al. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010;8(2):159–165.
   PubMed Web of Science ®Google Scholar
• As R, Wong BS, Camilleri M, et al. Chenodeoxycholate in females with irritable bowel syndrome-constipation: A pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 2010;139(5):1549–1558, 1558.e1541.
   PubMed Web of Science ®Google Scholar
• Gillberg P-G, Dahlström M, Starke I, et al. The ibat inhibition by a3309 – a potential mechanism for the treatment of constipation. Gastroenterology. 2010;138(5):S–224.
   Google Scholar
• Simren M, Bajor A, Gillberg PG, et al. Randomised clinical trial: the ileal bile acid transporter inhibitor a3309 vs. Placebo in patients with chronic idiopathic constipation–a double-blind study. Aliment Pharmacol Therapeut. 2011;34(1):41–50.
   PubMed Web of Science ®Google Scholar
• Wong BS, Camilleri M, McKinzie S, et al. Effects of a3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011;106(12):2154–2164.
   PubMed Web of Science ®Google Scholar
• Chey WD, Camilleri M, Chang L, et al. A randomized placebo-controlled phase iib trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011;106(10):1803–1812.
   PubMed Web of Science ®Google Scholar
• Nakajima A, Seki M, Taniguchi S. Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase ii, multicenter, double-blind, placebo-controlled randomized clinical trial. J Gastroenterol. 2018;53(4):525–534.
   PubMed Web of Science ®Google Scholar
• Nakajima AM S, Taniguchi S, Ohta A, et al. Short-term, randomized trial of efficacy and open-label, long-term safety of ileal bile acid transporter inhibitor, elobixibat, in chronic constipation. Lancet Gastroenterol Hepatol. 2018 Aug;3(8):537–547.
   Google Scholar
• Rudling M, Camilleri M, Graffner H, et al. Specific inhibition of bile acid transport alters plasma lipids and glp-1. BMC Cardiovasc Disord. 2015;15(75).
   PubMedGoogle Scholar
• Nicholls SJ, Tuzcu EM, Sipahi I, et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA. 2007;297(5):499–508.
   PubMed Web of Science ®Google Scholar
• Salmoirago-Blotcher E, Crawford S, Jackson E, et al. Constipation and risk of cardiovascular disease among postmenopausal women. Am J Med. 2011;124(8):714–723.
   PubMed Web of Science ®Google Scholar
• Charach G, Grosskopf I, Rabinovich A, et al. The association of bile acid excretion and atherosclerotic coronary artery disease. Therapeutic Adv Gastroenterol. 2011;4(2):95–101.
   PubMedGoogle Scholar
• Higgins PD, Johanson JF. Epidemiology of constipation in north America: a systematic review. Am J Gastroenterol. 2004;99(4):750–759.
   PubMed Web of Science ®Google Scholar
• Tamura A, Tomita T, Oshima T, et al. Prevalence and self-recognition of chronic constipation: results of an internet survey. J Neurogastroenterol Motil. 2016;22(4):677–685.
   PubMed Web of Science ®Google Scholar
• Nelson AD, Camilleri M, Chirapongsathorn S, et al. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis. Gut. 2017;66(9):1611–1622.
   PubMed Web of Science ®Google Scholar
• Sommers T, Corban C, Sengupta N, et al. Emergency department burden of constipation in the United States from 2006 to 2011. Am J Gastroenterol. 2015;110(4):572–579.
   PubMed Web of Science ®Google Scholar
• Ahren B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(5):2078–2084.
   PubMed Web of Science ®Google Scholar
• Esposito K, Chiodini P, Maiorino MI, et al. A nomogram to estimate the hba1c response to different dpp-4 inhibitors in type 2 diabetes: a systematic review and meta-analysis of 98 trials with 24 163 patients. BMJ Open. 2015;5(2):e005892.
   PubMed Web of Science ®Google Scholar